D. Loew

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats

Adrenergic α_2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice

Pharmacology and Management of the Vitamin K Antagonists

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration

Clopidogrel with or without Omeprazole in Coronary Artery Disease

A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis

Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis

Prevention of Venous Thromboembolism in General Surgical Patients

Oral anticoagulants in patients with coronary artery disease

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Clinical Pharmacokinetics of Ibuprofen

Platelet Activation and Atherothrombosis

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention

Mechanism of Action of St John???s Wort in Depression

Stroke

The Clinical Course of Pulmonary Embolism

Antithrombotic Therapy for Venous Thromboembolic Disease

Microbially controlled drug delivery to the colon

Oral Anticoagulants

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs

Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Diabetes and advanced glycation endproducts

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Hyperforin as a possible antidepressant component of hypericum extracts

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

The Pharmacology and Management of the Vitamin K Antagonists

Antithrombotic Therapy for Venous Thromboembolic Disease

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

The Relation Between Swelling Properties and Enzymatic Degradation of Azo Polymers Designed for Colon-Specific Drug Delivery

Direct enantiomeric separations by high performance liquid chromatography using cyclodextrins

Oral Anticoagulant Drugs

Hemorrhagic Complications of Anticoagulant Treatment

Pharmacokinetics and Bioavailability of Herbal Medicinal Products

Antithrombotic and Thrombolytic Therapy for Valvular Disease

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Hemorrhagic Complications of Anticoagulant Treatment

External validity of randomised controlled trials: “To whom do the results of this trial apply?”

Hemorrhagic Complications of Anticoagulant Treatment

Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

Parkinson's Disease

Secondary Prevention for Ischemic Heart Disease

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Activation of Carboxylic Acids via Self-Assembly Asymmetric Organocatalysis: A Combined Experimental and Computational Investigation

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)

Copper Active Sites in Biology

Polymeric Systems for Controlled Drug Release

Pharmacological interventions for somatoform disorders in adults

Acute effects of acetylsalicylic acid in patients with chronic renal insufficiency

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Prevention of arterial thromboembolism with acetylsalicylic acid

Long-term anticoagulant therapy after acute myocardial infarction

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

Aspirin and Other Platelet-Active Drugs

Review: A History of Cyclodextrins

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

Hemorrhagic Complications of Long-term Anticoagulant Therapy

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Polycyclic Polyprenylated Acylphloroglucinols

Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: A metaanalysis

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Avoiding Central Nervous System Bleeding During Antithrombotic Therapy

Hemorrhagic Complications of Anticoagulant Treatment

Multiple receptors for dopamine

Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)

Hemorrhagic Complications of Long-term Anticoagulant Therapy

Effects of bromocriptine on central dopaminergic receptors

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Colonic drug-targeting: In vitro release of ibuprofen from capsules coated with poly(ether-ester) azopolymers

Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods

Clinical Aspects of Platelet Inhibitors and Thrombus Formation

Global Burden of Cardiovascular Diseases

Antithrombotic agents in coronary artery disease

Low-Molecular-Weight Heparins

Management of Deep Vein Thrombosis and Pulmonary Embolism

Hemorrhagic Complications of Anticoagulant Treatment

Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs

Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

Catecholamines and aggression in animals

Chitosan Chemistry and Pharmaceutical Perspectives

Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.

Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats

[3H]Dihydroergocryptine binding in rat brain

Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater

Phytopharmaka in Forschung und klinischer Anwendung

S-Ibuprofen versus ibuprofen-racemate

Pharmacological differences between R(−)-and S(+)-ibuprofen

Pharmacokinetics of S(+)- and R(−)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis

High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids

Measurement of the bioavailability of aescin-containing extracts

Postoperative Thrombembolie-Prophylaxe mit Acetylsalicylsäure

STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPA

Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device

[The validity of radioimmunologic determination of bioavailability of beta-escin in horse chestnut extracts].

[Quantitative determination of the main metabolites of acetylsalicylic acid/2nd communication: the concentrations of salicylic acid and its metabolites in patients with renal insufficiency (author's transl)].

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.

Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs

Pharmacokinetics of thiamine derivatives especially of benfotiamine.

Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement

Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis.

Prophylaxis of postoperative thromboembolism by low dose heparin and by acetylsalicylic acid given simultaneously. A double blind study

[The treatment of transitory ischemic attacks with acetylsalicylic acid: results of a double-blind-study (author's transl)].

Acetylsalicylic acid, low dose heparin, and a combination of both substances in the prevention of postoperative thromboembolism. A double blind study

Inter-group aggression in mice